期刊文献+

结直肠癌组织中错配修复蛋白缺失的临床意义

Clinical significance of mismatch repair deficiency in colorectal cancer tissue
下载PDF
导出
摘要 目的分析错配修复蛋白缺失(dMMR)与结直肠癌临床病理特征的关系,探讨dMMR对结直肠癌诊治的临床意义。方法收集2021年12月—2023年7月济宁市第一人民医院胃肠外科经手术治疗的212例结直肠癌患者的相关临床病理资料,对dMMR与患者性别、年龄、肿瘤分化程度、TNM分期、T分期、N分期、有无脉管癌栓、有无神经侵犯、肿瘤部位及组织学类型等的相关性进行分析。结果212例结直肠癌患者中有12例dMMR(5.66%),其中32例右半结肠癌患者中有4例dMMR(12.50%);60例左半结肠癌患者中有6例dMMR(10.00%),120例直肠癌患者中有2例d MMR(1.67%),检出率差异有统计学意义(P<0.05)。dMMR与结直肠癌患者的性别、年龄、肿瘤分化程度、TNM分期、T分期、N分期、有无脉管癌栓及有无神经侵犯无关,仅与肿瘤部位、组织学类型有关。dMMR在右半结肠癌组织中和黏液腺癌组织中检出率更高。结论dMMR在不同类型结直肠癌患者中检出率差异有统计学意义,该指标检测有助于为患者提供个性化的精准诊疗方案并判断预后。 Objective To analyze the relationship between mismatch repair deficiency(dMMR)and clinical pathological characteristics of colorectal cancer,and explore the clinical significance of dMMR in diagnosis and treatment of colorectal cancer.Methods The clinical and pathological data of 212 patients with colon and rectal cancer undergoing surgical treatment in gastroenterology department of Jining First People's Hospital from December 2021 to July 2023 were collected,and the correlation of dMMR and gender,age,degree of differentiation,TNM stage,T stage,N stage,presence of vascular cancer thrombus,presence of nerve invasion,tumor location and histological type were analyzed.Results Among 212 patients,there were 12 cases(5.66%)with dMMR.Among the 32 patients with right colon cancer,there were 4 cases(12.50%)with dMMR.Among 60 patients with left colon cancer,only 6 cases(10.00%)had dMMR,while among 120 patients with rectal cancer,2 cases(1.67%)had dMMR.The differences were statistically significant(P<0.05).dMMR was not associated with gender,age,degree of differentiation,TNM stage,T stage,N stage,presence of vascular cancer thrombus or presence of nerve invasion in colorectal cancer patients,but related to tumor location and histological type.The incidence of dMMR was higher in right colon cancer tissue and mucinous adenocarcinoma tissue.Conclusion The difference in incidence of dMMR among colorectal cancer patients is statistically significant,and dMMR detection could help make personalized and accurate diagnosis and treatment plans for patients and determine prognosis.
作者 孙浩 Sun Hao(Department of Gastroenterology,Jining First People's Hospital,Jining 272011,Shandong,China)
出处 《实用检验医师杂志》 2024年第1期44-46,共3页 Chinese Journal of Clinical Pathologist
关键词 结直肠癌 错配修复蛋白 临床病理特征 Colorectal cancer Mismatch repair protein Clinicopathological characteristics
  • 相关文献

参考文献15

二级参考文献97

  • 1Sinicrope FA,Mahoney MR,Smyrk TC.肿瘤部位或决定结肠癌DNA错配修复功能缺陷的预后影响[J].中华结直肠疾病电子杂志,2013,2(4):208-208. 被引量:27
  • 2贾美君,蒋梅先.中医药治疗心力衰竭疗效评定方法及其评估标准客观化的思考[J].上海中医药杂志,2006,40(3):47-49. 被引量:8
  • 3Xu JM. Difference of colon cancer and rectal cancer-from the view of an oncological physician[ J ]. Chin J Oncol, 2010, 32 (5) :321- 323. DOIi 10.3760/cma.j.issn. 0253-3766. 2010.05.001.
  • 4Masoomi H, Buchberg B, Dang P, et al. Outcomes of right vs.left colectomy for colon cancer [ J]. J Gastrointest Surg, 2011, 15 ( 11 ) :2023-2028. DOI : 10.1007/s 11605-011-1655-y.
  • 5Iacopetta B. Are there two sides to colorectal cancer? [ J]. Int J Cancer, 2002, 101(5):403-408. DOI: 10.1002/ijc.10635.
  • 6Moritani K, Hasegawa H, Okabayashi K, et al. Difference in the recurrence rate between right-and left-sided colon cancer: a 17- year experience at a single institution [J]. Surg Today, 2014,44 (9) : 1685-1691. DOI: 10.1007/s00595-013-0748 -5.
  • 7Meguid RA, Slidell MB, Wolfgang CL, et al. Is there a difference in survival between right-versus left-sided colon cancers? [ J ]. Ann Surg Oncol, 2008, 15 (9): 2388-2394. DOI: 10. 1245/ s10434-008-0015-y.
  • 8Benedix F, Kube R, Meyer F, et al. Comparison of 17,641 patients with right-and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival [ J ]. Dis Colon Rectum, 2010, 53( 1 ) :57-64. DOI : lO.1007/DCR.Ob013e3181c703a4.
  • 9Weiss JM, Schumacher J, Allen GO, et al. Adjuvant chemotherapy for stage Ⅱ right-sided and left-sided colon cancer: analysis of SEER- medicare data I J ]. Ann Surg Oncol, 2014,21 (6) : 1781-1791. DOI: 10.1245/s10434-014-3631-8.
  • 10Price TJ, Beeke C, Ullah S, et al. Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease? [ J ]. Cancer, 2015,121 (6) :830-835. DOI : 10.1002/cncr.29129.

共引文献769

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部